Bath & Body Works, Inc. (BBWI) · Nov 19, 2026 · Earnings

Bath & Body Works earnings beat as sales outlook improves, profits lag

Beat — Adjusted EPS $0.26 vs $0.07-$0.12 Q3 guidance; sales $1.577B vs ~$1.55B consensus

Bath & Body Works earnings beat Q3 guidance and improved its 2026 sales outlook, but holiday profit guidance remains below last year.

Bath & Body Works is one year into its multi-year Consumer First Formula transformation, using product innovation, digital improvements and expanded distribution through partners such as Ulta and Amazon to reverse declining core-store sales. The prior quarter had already shown early traction—Direct returned to growth and full-year guidance improved—so this filing is more about proving the turnaround is carrying into the holiday setup than introducing a new strategy.

The quarter cleared a deliberately low bar by a meaningful margin. Third-quarter adjusted EPS of $0.26 was well above the company’s prior $0.07-$0.12 range and above the published consensus near $0.12; sales of $1.577 billion also exceeded the roughly $1.55 billion expectation. The underlying mix was better than the headline decline suggests: Direct sales rose 2.6% and International and Other rose 39.3%, partly offsetting a 4.3% drop in U.S. and Canadian stores (Revenue by Channel). The company said, “Our third quarter results exceeded our sales and adjusted earnings per share guidance.”

Q3 2026Q3 2025Consensus
Net sales (Financial Statements)$1,577M (-1.0%)$1,594M~$1,550M
Adjusted EPS (Adjusted Financial Information)$0.26$0.35~$0.12
Direct sales (Revenue by Channel)$307M (+2.6%)$299M
U.S./Canada store sales (Revenue by Channel)$1,169M (-4.3%)$1,222M

The sales outlook improved, but the profit trajectory did not. Full-year sales guidance now calls for a 2.1%-3.4% decline, better than the prior 2.5%-4.0% decline range, while adjusted EPS guidance was maintained at $2.60-$2.80. That is a constructive update to the turnaround narrative, but it is not a return to growth: third-quarter adjusted EPS fell to $0.26 from $0.35, and fourth-quarter reported EPS is guided to $1.41-$1.61 versus $1.99 last year. The company is still asking investors to view improving customer engagement and channel mix as early evidence of a future recovery, while current earnings remain under pressure. The filing states, “we have more work to do to drive consistent growth across our channels.” 〔0〕

The $500 million buyback is supportive but not the main takeaway. The authorization cannot begin until the existing January 2025 program is completed, so it changes future capital-allocation capacity rather than near-term operating performance. The balance sheet also benefited from $542 million of debt repayment year to date, but cash fell to $318 million from $953 million at the start of the year after debt repayment, dividends, repurchases and investment spending (Cash Flow statement). The company forecasts $600 million of full-year free cash flow, which provides the intended funding source, but the holiday quarter remains the immediate test.

Bottom line: This is a modest step forward for the transformation: the business beat a low Q3 bar and improved its sales outlook, especially outside physical stores. But the filing still describes a recovery in progress, not a completed turnaround, because holiday sales and profits remain below last year’s levels and adjusted full-year earnings guidance was not raised.

What to watch next

Q4 earnings report, late February 2027

Original filing on SEC EDGAR

More Bath & Body Works, Inc. news

Bath & Body Works earnings beat as sales outlook improves, profits lag | BBWI Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.